FDA Approves Lilly’s Once-Weekly Shot For Diabetes

The FDA said today that it had approved dulaglutide, Lilly’s once-weekly injection to control blood sugar in adults with type 2 diabetes. The drug will be marketed under the brand name of Trulicity.

Click here to read the full post on Forbes.

 

 

Leave a Reply

%d bloggers like this: